Identification of a novel, transactivation-defective splicing variant of p53 gene in patients with chronic lymphocytic leukemia

Leukemia Research

Volumn 32, Issue 3, 2008, Pages 395-400

  Pekova, Sona ^a   Cmejla, Radek ^b   Smolej, Lukas ^c   Kozak, Tomas ^a,d   Spacek, Martin ^d   Prucha, Miroslav ^a  

^a NA HOMOLCE HOSPITAL   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

CLL; FASAY; p53 splicing

Indexed keywords

PROTEIN P53;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA ISOLATION; RNA SPLICING;

ALTERNATIVE SPLICING; BASE SEQUENCE; GENES, P53; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 39749122923     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.06.022     Document Type: Article

References (25)

1. Lane D.P. Cancer. p53, guardian of the genome. Nature 358 (1992) 15-16
2. Lane D.P., and Fischer P.M. Turning the key on p53. Nature 427 (2004) 789-790
3. Mills A.A. p53: link to the past, bridge to the future. Genes Dev 19 (2005) 2091-2099
4. Honda R., Tanaka H., and Yasuda H. Oncoprotein MDM-2 is an ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420 (1997) 25-27
5. Lahav G., Rosenfeld N., Sigal A., Geva-Zatorsky N., Levine A.J., Elowitz M.B., et al. Dynamics of the p53-MDM-2 feedback loop in individual cells. Nat Genet 36 (2004) 147-150
6. Momand J., Zambetti G.P., Olson D.C., George D., and Levine A.J. The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69 (1992) 1237-1245
7. Takekawa M., Adachi M., Nakahata A., Nakayama I., Itoh F., Tsukuda H., et al. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. Embo J 19 (2000) 6517-6526
8. Fiscella M., Zhang H., Fan S., Sakaguchi K., Shen S., Mercer W.E., et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci USA 94 (1997) 6048-6053
9. Okamoto K., Li H., Jensen M.R., Zhang T., Taya Y., Thorgeirsson S.S., et al. Cyclin G recruits PP2A to dephosphorylate MDM-2. Mol Cell 9 (2002) 761-771
10. Sherr C.J. Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 6 (2006) 663-673
11. Appella E., and Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268 (2001) 2764-2772
12. Barlev N.A., Liu L., Chehab N.H., Mansfield K., Harris K.G., Halazonetis T.D., et al. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell 8 (2001) 1243-1254
13. Unger T., Sionov R.V., Moallem E., Yee C.L., Howley P.M., Oren M., et al. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 18 (1999) 3205-3212
14. Unger T., Juven-Gershon T., Moallem E., Berger M., Vogt Sionov R., Lozano G., et al. Critical role for Ser20 of human p53 in the negative regulation of p53 by MDM-2. Embo J 18 (1999) 1805-1814
15. Chao C., Hergenhahn M., Kaeser M.D., Wu Z., Saito S., Iggo R., et al. Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses. J Biol Chem 278 (2003) 41028-41033
16. Bourdon J.C., Fernandes K., Murray-Zmijewski F., Liu G., Diot A., Xirodimas D.P., et al. p53 isoforms can regulate p53 transcriptional activity. Genes Dev 19 (2005) 2122-2137
17. Smardova J. FASAY: a simple functional assay in yeast for identification of p53 mutation in tumors. Neoplasma 46 (1999) 80-88
18. Smardova J., Pavlova S., Svitakova M., Grochova D., and Ravcukova B. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124. Oncol Rep 14 (2005) 901-907
19. Harms K.L., and Chen X. The C terminus of p53 family proteins is a cell fate determinant. Mol Cell Biol 25 (2005) 2014-2030
20. Nissim-Rafinia M., and Kerem B. Splicing regulation as a potential genetic modifier. Trends Genet 18 (2002) 123-127
21. Rohaly G., Chemnitz J., Dehde S., Nunez A.M., Heukeshoven J., Deppert W., et al. A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint. Cell 122 (2005) 21-32
22. Boldrup L., Bourdon J.C., Coates P.J., Sjostrom B., and Nylander K. Expression of p53 isoforms in squamous cell carcinoma of the head and neck. Eur J Cancer 43 (2007) 617-623
23. Goldschneider D., Horvilleur E., Plassa L.F., Guillaud-Bataille M., Million K., Wittmer-Dupret E., et al. Expression of C-terminal deleted p53 isoforms in neuroblastoma. Nucleic Acids Res 34 (2006) 5603-5612
24. Nissim-Rafinia M., and Kerem B. The splicing machinery is a genetic modifier of disease severity. Trends Genet 21 (2005) 480-483
25. Kato S., Han S.Y., Liu W., Otsuka K., Shibata H., Kanamaru R., et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA 100 (2003) 8424-8429